Royal Bank of Canada’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92M | Buy |
503,707
+501,761
| +25,784% | +$1.91M | ﹤0.01% | 3056 |
|
|
2025
Q1 | $5K | Buy |
1,946
+1,138
| +141% | +$2.92K | ﹤0.01% | 5982 |
|
|
2024
Q4 | $3K | Sell |
808
-2,146
| -73% | -$7.97K | ﹤0.01% | 6168 |
|
|
2024
Q3 | $13K | Buy |
2,954
+276
| +10% | +$1.22K | ﹤0.01% | 5801 |
|
|
2024
Q2 | $12K | Buy |
2,678
+1,019
| +61% | +$4.57K | ﹤0.01% | 5886 |
|
|
2024
Q1 | $8K | Sell |
1,659
-8,018
| -83% | -$38.7K | ﹤0.01% | 5842 |
|
|
2023
Q4 | $61K | Buy |
9,677
+6,061
| +168% | +$38.2K | ﹤0.01% | 5369 |
|
|
2023
Q3 | $26K | Buy |
3,616
+1,724
| +91% | +$12.4K | ﹤0.01% | 5595 |
|
|
2023
Q2 | $19K | Buy |
+1,892
| New | +$19K | ﹤0.01% | 5786 |
|
|
2022
Q4 | – | Sell |
-12
| Closed | – | – | 7092 |
|
|
2022
Q3 | $0 | Sell |
12
-2,044
| -99% | – | ﹤0.01% | 7229 |
|
|
2022
Q2 | $10K | Buy |
2,056
+2,000
| +3,571% | +$9.73K | ﹤0.01% | 5925 |
|
|
2022
Q1 | $0 | Sell |
56
-17
| -23% | – | ﹤0.01% | 7381 |
|
|
2021
Q4 | $0 | Sell |
73
-6
| -8% | – | ﹤0.01% | 7231 |
|
|
2021
Q3 | $1K | Sell |
79
-795
| -91% | -$10.1K | ﹤0.01% | 6974 |
|
|
2021
Q2 | $5K | Buy |
874
+33
| +4% | +$189 | ﹤0.01% | 6569 |
|
|
2021
Q1 | $6K | Buy |
841
+375
| +80% | +$2.68K | ﹤0.01% | 6497 |
|
|
2020
Q4 | $2K | Buy |
+466
| New | +$2K | ﹤0.01% | 6310 |
|
|
2020
Q2 | – | Sell |
-117
| Closed | -$1K | – | 6298 |
|
|
2020
Q1 | $1K | Buy |
+117
| New | +$1K | ﹤0.01% | 5978 |
|
|
2018
Q4 | – | Sell |
-10,227
| Closed | -$60K | – | 6071 |
|
|
2018
Q3 | $60K | Sell |
10,227
-9,843
| -49% | -$57.7K | ﹤0.01% | 4550 |
|
|
2018
Q2 | $113K | Buy |
+20,070
| New | +$113K | ﹤0.01% | 4174 |
|